Search Existing Tissue Requests

The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.


Search Terms:


Investigator: Oscar Harari

Project Title: Mendelian randomization for unbiased biomarker discovery for AD and other complex traits

Date: December 21, 2021 at 5:02 pm

Request ID: T1727

Aim 1: To identify common and rare genetic variants and pathways associated with protein levels in plasma, CSF and brain tissue

Aim 2: To determine whether the variants associated with plasma, CSF and brain protein levels are also associated with AD or other complex traits

Aim 3:

Aim 4:


Investigator: Sally Temple/Celeste Karch

Project Title: iPSC Modeling of AD Using Progerin

Date: December 21, 2021 at 5:02 pm

Request ID: T1720

Aim 1: Is prelamin A expression and processing perturbed in AD brains?

Aim 2:

Aim 3:

Aim 4:


Investigator: Fujirebio Diagnostics Inc

Project Title: Fujirebio ADRC Sample Request

Date: December 21, 2021 at 5:02 pm

Request ID: T1721

Aim 1: to establish a Lumipulse G β-Amyloid 1-42 assay cutoff for distinguishing AD vs. HC in an autopsy confirmed LOAD population with appropriate clinical data.

Aim 2:

Aim 3:

Aim 4:


Investigator: Chihiro Sato

Project Title: Quantitative analyses of tau phosphorylation and isoforms in Brain, CSF, and cell culture models

Date: December 21, 2021 at 5:02 pm

Request ID: T1722

Aim 1: To establish a comprehensive, quantitative profile of tau in human brain and CSF in AD and controls

Aim 2: To validate novel CSF tau phosphorylation ratios as new biomarkers of AD

Aim 3:

Aim 4:


Investigator: Kevin Yarasheski

Project Title: Analytical validation & confirmation of a novel blood test for brain amyloidosis

Date: December 21, 2021 at 5:02 pm

Request ID: T1723

Aim 1: Conduct the analytical validation of a novel, quantitative mass spectrometry-based plasma A� isoform assay.

Aim 2: Confirm the ability of this novel assay to distinguish between people with/without brain amyloidosis.

Aim 3: Calculate the assay accuracy (ROC AUC) and threshold plasma A�42/A�40 ratio that distinguishes between brain amyloid positive vs negative.

Aim 4:


Investigator: Dwight German

Project Title: Pesticide exposure and Alzheimer’s disease

Date: December 21, 2021 at 5:02 pm

Request ID: T0912-A

Aim 1: Validate DDE levels in tissue samples from samples previously provided.

Aim 2: Determine whether DDE brain levels are the same in different brain regions

Aim 3:

Aim 4:


Investigator: Chihiro Sato

Project Title: Quantitative analysis of tau phosphorylation and isoforms in Brain, CSF, and cell culture models

Date: December 21, 2021 at 5:02 pm

Request ID: T1722-A

Aim 1: The goal of this pilot experiment is to test the hypothesis that there are no brain regional differences in the phosphorylation profile of soluble tau in Alzheimer’s disease (AD) brain.

Aim 2:

Aim 3:

Aim 4:


Investigator: Tammie Benzinger

Project Title: Association between MRI-based neuroinflammation markers and CSF biomarkers of inflammation

Date: December 21, 2021 at 5:02 pm

Request ID: T1724

Aim 1: To improve and extend the ADRC�s neuroinflammation imaging and biomarker dataset

Aim 2: Validate a novel magnetic resonance imaging (MRI) method, diffusion based spectrum imaging (DBSI), as a biomarker of neuroinflammation in AD

Aim 3: Examine the relationship of DBSI cell signal to neuroinflammation-related CSF biomarkers

Aim 4: Determine the spatial distribution of DBSI which relates best to CSF neuroinflammation biomarkers


Investigator: Amir Levine

Project Title: Identifying non-invasive predictive markers of Alzheimer’s Disease

Date: December 21, 2021 at 5:02 pm

Request ID: T1725

Aim 1: To identify non-invasive molecular markers from frozen EDTA plasma that distinguish subjects with MCI only from those with MCI who convert to AD

Aim 2:

Aim 3:

Aim 4:


Investigator: Dominique Campion

Project Title: Investigate of the pathophysiological mechanisms driven by the MAPT duplication

Date: December 21, 2021 at 5:02 pm

Request ID: T1726

Aim 1: Identification of novel MAPT duplication carriers: targeted screening of the MAPT gene duplication by QMPSF

Aim 2:

Aim 3:

Aim 4: